Closest to BPL-003 is CYB004
BPL-003 (Beckley / $atai): Phase 2b TRD topline — rapid effect by Day 2, ~10–12pt MADRS drop sustained to 8wks.
CYB004 $cybn : Early data showed up to 100% response & 92% remission at 4wks (MDD+SSRIs). Phase 2 GAD fully enrolled, topline due Q1'26.
Weak hands who sold $CYBN don’t see the full picture.
If the data was bad, that’s one thing. But the data is best-in-class.
Management changes signal the data is too good for the old CEO. The previous CEO doesn’t affect the data, only the progress.
$CYBN data is strong — this is the main.
Management was weak and needs to be changed.
How could you say a few months ago that CYB004 data would be in August, when it will actually be at year end?
Overall, Cybin is extremely undervalued and has become an even better target for M&A
If $CYBN CYB004 achieves even 40–60% MADRS remission in GAD, it would match or outperform SSRIs — with faster onset and longer durability.
If CYB004 the adjunctive effect with SSRIs holds, it would outperform every current standard GAD treatment in both speed and durability.
32 Followers 1K FollowingY’all click on my link on my bio to join my luffa chat /telegram channel for more psychedelic discoveries
Luffa chat: https://t.co/PLeYx5XA94
200 Followers 1K FollowingAKA Joni of the Mectizan Donation Program (tweets my own), Enemy of Tropical Diseases, World Wanderer, Global Health and Marine Conservation advocate.
3K Followers 866 Following40x #Salesforce Dev/Architect. Inventor of Dumpster__c. Always take the stage like it's the last day of your life. #TrailblazerCommunity #salesforceArchitect
176K Followers 46 FollowingCo-founder of @Chainlink: industry-standard for creating the verifiable web and bringing the whole world onchain. We're Hiring: https://t.co/0xiQfsV9Sz
85K Followers 1 FollowingWe're dedicated to supporting open-source, decentralized technologies that securely & seamlessly connect crypto. We are stewards of the @wormhole ecosystem.
112K Followers 2K FollowingAsset manager founded in 1955. We make ETFs & more. Tweets by vaneck intern™🪶 Interactions ≠ endorsements. Disclosures: https://t.co/Z3FWkV2SAZ.
64K Followers 982 FollowingWorld’s largest tokenization platform.
$4B+ in assets across BUIDL, USDtb, VBILL + more.
Backed by: @BlackRock @MorganStanley
14K Followers 2K Followingpsychiatrist, author, wife/mom, musician, MDMA & cannabis researcher, harm reductionist, medical advisor to MAPS ++
GOOD CHEMISTRY: The Science of Connection.
53K Followers 8K FollowingClimate and clean energy investor. Author of 5 books. Energy & Environment co-chair @SingularityU. Trying to build a better world.
43K Followers 6K FollowingFounder @EigenLayer ($20B+ AUM protocol) • Verifiable Cloud for the Agentic Era (backed by a16z) • Ex-Prof @UW: Genomics, AI & Info Theory.
24K Followers 249 FollowingMindMed is a clinical stage biopharma company developing psychedelics and other novel treatments for brain health disorders. $MNMD $MMED
120K Followers 267 FollowingDaily updates for Cathie Wood's Ark Invest fund. | Visit Ark Invest's official website below! | Not affiliated with Ark in any way.
504K Followers 1K FollowingProfessor @Harvard researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own 🙏✌️
21K Followers 74 FollowingEmpowering a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact in psychedelic medicine and beyond.
1.6M Followers 2K FollowingProfessor of Neurobiology and Ophthalmology at Stanford Medicine • Host of Huberman Lab • Focused on science and health research and public education
90K Followers 188 FollowingFounder: @McKennaAcademy.
The reedition of Brotherhood of the Screaming Abyss: My Life with Terence McKenna is now available!
3K Followers 429 FollowingCo-Founder and ex-CEO of @ATAI_life - NASDAQ : $ATAI. Passionate about building companies, mental health and biotech. Views are my own. No investment advice.
79 Followers 0 FollowingTo educate and advocate for the development and accessibility of safe and effective prescription psychedelic medicines for patients.
1K Followers 823 FollowingVenturing into the world of psychedelic drug development, research, investing, and more. Sharing insights and interviewing leading figures in the field.